Elos Medtech appoints Operational Excellence Director
Elos Medtech appoints Conny Jakobsson, Managing Director of Elos Medtech Tianjin in China, to Operational Excellence Director for Elos Medtech.
At Elos Medtech we remain committed to growth and the positive transformation of our business. One of our strategic focus areas ’Operational Excellence and Continuous Improvements’ will support our growth and profitability targets by systematically developing our operations, ensuring increased capacity and improving the competitiveness of our offerings to customer partners. We are now strengthening this area by appointing Conny Jakobsson as Operational Excellence Director.
‘I am very happy that Conny has taken on the role to lead and develop our focus area ’Operational Excellence and Continuous Improvements’. By performing systematic diagnostics of our operations today, creating production system with defined targets and implementing the relevant improvement measures, we will create the essential conditions for future growth, better gross margins and increased profitability’, says Jan Wahlström, CEO and President. ‘Since Conny joined our company, he has shown excellent results to improve the processes in our Chinese facility.’
‘Within operational excellence, we will in collaboration combine our best practices at Elos Medtech and create a continuous improvement culture, with team work and cross-site functional groups, aligning our factories to create a similar ‘window’ to our customers’, says Conny Jakobsson, Managing Director of Elos Medtech Tianjin. Conny will remain in China and continue in parallel in his current role.
Elos Medtech is one of the leading development and production partners for medical technology products and components in the world, with focus on dental and orthopedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and the US. Customers are medical technology companies operating internationally.
Elos Medtech employs more than 550 people worldwide and generates revenue that exceeds MSEK 600. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.
Gothenburg, March 8, 2019
Elos Medtech AB (publ)
For further information, contact:
Jan Wahlström, President and CEO, +46 70-212 18 89, firstname.lastname@example.org
Conny Jakobsson, Managing Director Elos Medtech Tianjin, +86 139 10 82 72 83, email@example.com
This is the type of information that Elos Medtech AB (publ) is obliged to publish in accordance with the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was issued for publication by the contact persons stated above on March 8, 2019, at 13.00 (CET).
For additional information about the Elos Medtech Group, visit www.elosmedtech.com